BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 11369412)

  • 1. Effects of all-trans-retinoic acid and arsenic trioxide on the hemostatic disturbance associated with acute promyelocytic leukemia.
    Zhao W; Wang H; Wang X; Wu F; Guo W; Qu B; Shen Z; Wang Z
    Thromb Res; 2001 May; 102(3):197-204. PubMed ID: 11369412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemostatic abnormalities associated with acute promyelocytic leukemia and corrective effects of all-trans-retinoic acid or arsenic trioxide treatment.
    Zhao W; Wang X; Guo W; Qu B; Wang H; Shen Z; Chen Z; Wang Z
    Chin Med J (Engl); 2000 Mar; 113(3):236-40. PubMed ID: 11775254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A study of tissue factor expression and hemostatic molecular markers in patients with acute promyelocytic leukemia].
    Wu F; Wang X; Zhao W; Wang H; Shen Z
    Zhonghua Nei Ke Za Zhi; 2001 Jan; 40(1):36-9. PubMed ID: 11798557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The impact of arsenic trioxide or all-trans retinoic acid treatment on coagulopathy in acute promyelocytic leukemia].
    Zhang X; Zhou H; Song S; Qiao Z; Yang L; Hu Y
    Zhonghua Nei Ke Za Zhi; 2001 Dec; 40(12):829-33. PubMed ID: 16206674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effects of all-trans retinoic acid and arsenic trioxide on tissue factor expression of acute promyelocytic leukemia cells].
    Guo W; Wang H; Zhao W
    Zhonghua Yi Xue Za Zhi; 2000 May; 80(5):327-31. PubMed ID: 11798779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Tissue factor expression during all-trans retinoic acid or arsenic trioxide treatment in acute promyelocytic leukemia].
    Zhao W; Wang H; Guo W
    Zhonghua Xue Ye Xue Za Zhi; 1998 Sep; 19(9):473-6. PubMed ID: 11189487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arsenic trioxide, retinoic acid and Ara-c regulated the expression of annexin II on the surface of APL cells, a novel co-receptor for plasminogen/tissue plasminogen activator.
    Zhang X; Zhou H; Wang J; Yang L; Hu Y; Shen G; Guo P; Qiao Z; Song S
    Thromb Res; 2002 Apr; 106(1):63-70. PubMed ID: 12165291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of arsenic trioxide or retinoic acid on mRNA and protein expression of tissue factor and thrombomodulin and procoagulant activity in NB4 cells].
    Zhang XH; Hu Y; Hong M; Xia LH; Guo T; Shen GX; Wei WN; Song SJ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Apr; 15(2):391-5. PubMed ID: 17493354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of all-trans retinoic acid and arsenic trioxide on tissue factor expression in acute promyelocytic leukemia cells.
    Guo W; Wang H; Zhao W; Zhu J; Ju B; Wang X
    Chin Med J (Engl); 2001 Jan; 114(1):30-4. PubMed ID: 11779431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of all-trans retinoic acid on procoagulant and fibrinolytic activities of cultured blast cells from patients with acute promyelocytic leukemia.
    De Stefano V; Teofili L; Sica S; Mastrangelo S; Di Mario A; Rutella S; Salutari P; Rumi C; d'Onofrio G; Leone G
    Blood; 1995 Nov; 86(9):3535-41. PubMed ID: 7579461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of all-trans retinoic acid or chemotherapy on the molecular regulation of systemic blood coagulation and fibrinolysis in patients with acute promyelocytic leukemia.
    Tallman MS; Lefèbvre P; Baine RM; Shoji M; Cohen I; Green D; Kwaan HC; Paietta E; Rickles FR
    J Thromb Haemost; 2004 Aug; 2(8):1341-50. PubMed ID: 15304040
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tissue factors on acute promyelocytic leukemia and endothelial cells are differently regulated by retinoic acid, arsenic trioxide and chemotherapeutic agents.
    Zhu J; Guo WM; Yao YY; Zhao WL; Pan L; Cai X; Ju B; Sun GL; Wang HL; Chen SJ; Chen GQ; Caen J; Chen Z; Wang ZY
    Leukemia; 1999 Jul; 13(7):1062-70. PubMed ID: 10400422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of all-trans retinoic acid, arsenic trioxide and daunorubicin on tissue factor expression in NB4 cells].
    Guo W; Zhu J; Wang H
    Zhonghua Xue Ye Xue Za Zhi; 1999 Sep; 20(9):453-5. PubMed ID: 11721405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical study on the fibrinolytic activity in patients with acute promyelocytic leukemia].
    Liu YH; Wang ZY; Zhang W; Dai L; Shen WH; Ruan CG
    Zhonghua Xue Ye Xue Za Zhi; 2009 Mar; 30(3):145-9. PubMed ID: 19642359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term follow-up of hemostatic molecular markers during remission induction therapy with all-trans retinoic acid for acute promyelocytic leukemia. Keio Hematology-Oncology Cooperative Study Group (KHOCS).
    Watanabe R; Murata M; Takayama N; Tokuhira M; Kizaki M; Okamoto S; Kawai Y; Watanabe K; Murakami H; Kikuchi M; Nakamura S; Ikeda Y
    Thromb Haemost; 1997 Apr; 77(4):641-5. PubMed ID: 9134635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Role of Microparticles Derived from Acute Promyelocytic Leukemia Cells in Coagulopathy].
    Zhang YM; Chen B; Wu LY; Hou JX; Fu JY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Jun; 25(3):693-698. PubMed ID: 28641620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of ATRA and ATO on the expression of tissue factor in NB4 acute promyelocytic leukemia cells and regulatory function of the inflammatory cytokines TNF and IL-1β.
    Dunoyer-Geindre S; Rivier-Cordey AS; Tsopra O; Lecompte T; Kruithof EKO
    Ann Hematol; 2017 Jun; 96(6):905-917. PubMed ID: 28343272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decreased tissue factor and tissue-plasminogen activator antigen in relapsed acute promyelocytic leukemia.
    Nakasaki T; Wada H; Mori Y; Okugawa Y; Watanabe R; Nishikawa M; Gabazza EC; Masuya M; Kageyama S; Kumeda K; Kato H; Shiku H
    Am J Hematol; 2000 Jul; 64(3):145-50. PubMed ID: 10861807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coagulation disorders associated with acute promyelocytic leukemia: corrective effect of all-trans retinoic acid treatment.
    Dombret H; Scrobohaci ML; Ghorra P; Zini JM; Daniel MT; Castaigne S; Degos L
    Leukemia; 1993 Jan; 7(1):2-9. PubMed ID: 8418375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phosphatidylserine exposure and procoagulant activity in acute promyelocytic leukemia.
    Zhou J; Shi J; Hou J; Cao F; Zhang Y; Rasmussen JT; Heegaard CW; Gilbert GE
    J Thromb Haemost; 2010 Apr; 8(4):773-82. PubMed ID: 20102487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.